Patients Variables | AML group | CD85k + Ve | AML subgroup (MLIL) | Control | p-value |
Patients No | 32 |
| 14 | 15 | NS |
Age (years) Median (range) <35 >35 |
19 (2 - 80) 14 (12) 18 (7) |
|
20(2 - 74) 10 4 |
15 (3 - 60)
|
NS 0.06 S 0.03 NS 0.08 |
Sex M/F |
19/13 |
(10/9) |
6/8 |
8/7 |
NS 0.5 |
Hepatomegaly Normal size | 18 (12) 14 (7) |
| 12 2 | Normal | NS 0.3 |
Splenomegaly Normal size | 20 (15) 12 (4) |
| 12 2 | Normal | NS 0.4 |
Lymphadenopathy No lymphadenopathy | 14 (10) 18 (9) |
| 10 2 | Normal | NS 0.2 |
WBCs × 109/l Range <50 >50 |
1.7 - 245 21 11 |
|
23 - 245 9 5 | 3.2 - 12.8
|
S 0.02 |
Hb g/dl Range <7 >7 |
3.7 - 12.6 19 13 |
|
4.5 - 8 10 4 |
11 - 13.5
|
S 0.023 |
Platelets × 109/l Range <100 >100 |
12 - 456 24 8 |
|
14 - 38 14 0 |
243 - 427
|
S 0.02 |
P.Bl. blasts % Range |
11 - 91 |
|
14 - 69 |
0.0 |
NS 0.06 |
B.M blasts % Range |
24 - 93 |
|
23 - 78 |
0.0 |
NS 0.5 |
CD85k + Ve % Range Mean ± SD |
(0.63 - 87.6) 26.92 ± 25.29 | (19) |
(23 - 87.6) 14 |
0.0 | HS 0.001
|